<DOC>
	<DOC>NCT02280603</DOC>
	<brief_summary>This study is designed to explore the efficacy and safety of DA-4001 after topical application in male patients with androgenetic alopecia Design : Randomized, double-blind, active-controlled study Investigational Product : Finasteride, minoxidil</brief_summary>
	<brief_title>Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application</brief_title>
	<detailed_description />
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<mesh_term>Minoxidil</mesh_term>
	<criteria>Basic and specific(BASP) classification : basic type is M2 or C2 and specific type is V1,V2 or F1,F2 Evidence of hair loss other than androgenetic alopecia Use of finasteride, dutasteride within previous 12 months Use of minoxidil within previous 6 months Use of androgenic or antiandrogenic agents within previous 6 months Use of steroid agents for local application to scalp or systemic application within previous 1 month History of hair transplantation, scalp reduction Coronary artery disease, arrhythmia, congestive heart failure, valvular haert disease, angina pectoris</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>